FOXO TECHNOLOGIES INC. Fair Value Adjustment of Warrants
FOXO TECHNOLOGIES INC. (FOXO) reported Fair Value Adjustment of Warrants of -$41.25 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2026-08-14
- FOXO TECHNOLOGIES INC. fair value adjustment of warrants for the quarter ending 2025-12-31 was -$496.00, a 101.46% decline year-over-year.
- FOXO TECHNOLOGIES INC. fair value adjustment of warrants for the quarter ending 2025-09-30 was -$1.58K, a 122.57% decline year-over-year.
- FOXO TECHNOLOGIES INC. fair value adjustment of warrants for the quarter ending 2025-06-30 was -$7.58K.
- FOXO TECHNOLOGIES INC. fair value adjustment of warrants for the quarter ending 2025-03-31 was -$31.59K.
- FOXO TECHNOLOGIES INC. fair value adjustment of warrants for fiscal 2025 was -$41.25K, a 227.20% decline from fiscal 2024.
- FOXO TECHNOLOGIES INC. fair value adjustment of warrants for fiscal 2024 was $32.42K.
- FOXO TECHNOLOGIES INC. fair value adjustment of warrants for fiscal 2023 was -$302.54K.
- FOXO TECHNOLOGIES INC. fair value adjustment of warrants for fiscal 2022 was -$2.08M.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 3 month as first filed | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 6 month as first filed | Fair Value Adjustment of Warrants 8 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 9 month as first filed | Fair Value Adjustment of Warrants 12 month | Fair Value Adjustment of Warrants 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | -$496.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | -$2.08K derived: sum of 2 quarters · filed 2026-04-15 | -$9.65K derived: sum of 3 quarters · filed 2026-08-14 | -$41.25K 10-K · filed 2026-04-15 | |||||
| 2025-09-30 | -$1.58K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$9.16K derived: sum of 2 quarters · filed 2026-08-14 | -$40.75K 10-Q · filed 2025-11-10 | -$6.78K derived: sum of 4 quarters · filed 2026-08-14 | |||||
| 2025-06-30 | -$7.58K 10-Q · filed 2026-08-14 | -$39.17K 10-Q · filed 2026-08-14 | -$5.20K derived: sum of 3 quarters · filed 2026-08-14 | $1.80K derived: sum of 4 quarters · filed 2026-08-14 | |||||
| 2025-03-31 | -$31.59K 10-Q · filed 2026-05-15 | $2.37K derived: sum of 2 quarters · filed 2026-05-15 | $9.37K derived: sum of 3 quarters · filed 2026-05-15 | $9.37K derived: sum of 4 quarters · filed 2026-05-15 | |||||
| 2024-12-31 | $33.97K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $40.97K derived: sum of 2 quarters · filed 2026-04-15 | $40.97K derived: sum of 3 quarters · filed 2026-04-15 | $32.42K 10-K · filed 2026-04-15 | |||||
| 2024-09-30 | $7.00K 10-Q · filed 2024-11-19 | $7.00K derived: sum of 2 quarters · filed 2025-08-19 | -$1.54K 10-Q · filed 2025-11-10 | -$1.00K 10-Q · filed 2024-11-19 | -$59.63K derived: sum of 4 quarters · filed 2025-08-19 | ||||
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q/A 3 month · filed 2025-08-19 | -$8.09K 10-Q · filed 2025-08-19 | -$8.00K 10-Q · filed 2024-08-19 | -$66.63K derived: sum of 3 quarters · filed 2025-08-19 | -$102.63K derived: sum of 4 quarters · filed 2025-08-19 | ||||
| 2024-03-31 | -$8.09K 10-Q/A · filed 2025-08-19 | -$8.00K 10-Q · filed 2024-06-28 | -$66.63K derived: sum of 2 quarters · filed 2025-08-19 | -$102.63K derived: sum of 3 quarters · filed 2025-08-19 | -$310.63K derived: sum of 4 quarters · filed 2025-08-19 | ||||
| 2023-12-31 | -$58.54K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | -$94.54K derived: sum of 2 quarters · filed 2025-04-15 | -$302.54K derived: sum of 3 quarters · filed 2025-04-15 | -$302.54K 10-K · filed 2025-04-15 | -$303.00K 10-K · filed 2024-06-06 | ||||
| 2023-09-30 | -$36.00K 10-Q · filed 2024-11-19 | -$244.00K derived: sum of 2 quarters · filed 2024-11-19 | -$244.00K 10-Q · filed 2024-11-19 | ||||||
| 2023-06-30 | -$208.00K 10-Q · filed 2024-08-19 | -$208.00K 10-Q · filed 2024-08-19 | |||||||
| 2022-12-31 | -$727.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2024-06-06 | -$2.08M derived: sum of 2 quarters · filed 2024-06-06 | -$2.08M 10-K · filed 2024-06-06 | ||||||
| 2022-09-30 | -$1.35M 10-Q/A · filed 2024-06-04 | -$1.35M 10-Q/A · filed 2024-06-04 | |||||||
| 2022-03-31 | $7.43M 10-Q · filed 2023-05-11 | ||||||||
| 2021-06-30 | $1.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | -$3.54M 10-Q · filed 2021-08-16 | |||||||
| 2021-03-31 | -$5.20M 10-Q · filed 2021-05-17 | ||||||||
| 2020-12-31 | $1.75M 10-K/A · filed 2021-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |